MPS Pharmaa Limited (BOM:531686)

India flag India · Delayed Price · Currency is INR
1.650
0.00 (0.00%)
At close: Mar 16, 2026
Market Cap31.53M +371.4%
Revenue (ttm)204.00 -100.0%
Net Income-9.40M
EPS-0.50
Shares Out19.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume99,000
Average Volume9,837
Open1.650
Previous Close1.650
Day's Range1.570 - 1.650
52-Week Range1.570 - 3.510
Beta-0.04
RSI27.71
Earnings DateMay 29, 2026

About MPS Pharmaa

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 18
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531686
Full Company Profile

Financial Performance

In fiscal year 2025, MPS Pharmaa's revenue was 477,204, a decrease of -49.05% compared to the previous year's 936,669. Losses were -8.98 million, 8.05% more than in 2024.

Financial Statements